Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,773 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis.
Chander A, Iacovacci J, Pellon A, Kataria R, Grigoriadis A, Maher J, Sears C, Bachrach G, Urbano TG, Lei M, Petkar I, Kong A, Ng T, Orlandi E, Iacovelli NA, De Cecco L, Serafini MS, Moyes D, Rancati T, Ferreira MR. Chander A, et al. Among authors: kong a. Cancer Commun (Lond). 2024 Aug;44(8):879-883. doi: 10.1002/cac2.12588. Epub 2024 Jul 6. Cancer Commun (Lond). 2024. PMID: 38970403 Free PMC article. No abstract available.
Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort Study.
Vasiliadou I, Breik O, Baker H, Leslie I, Sim VR, Hegarty G, Michaelidou A, Nathan K, Hartley A, Good J, Sanghera P, Fong C, Urbano TG, Lei M, Petkar I, Ferreira MR, Nutting C, Wong KH, Newbold K, Harrington K, Bhide S, Kong A. Vasiliadou I, et al. Among authors: kong a. Cancers (Basel). 2021 Mar 19;13(6):1413. doi: 10.3390/cancers13061413. Cancers (Basel). 2021. PMID: 33808781 Free PMC article.
TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapy.
Sambasivan K, Sassoon I, Thavaraj S, Kennedy R, Doss G, Michaelidou A, Odell E, Sandison A, Hall G, Morgan P, Collins LHC, Lyons A, Cascarini L, Fry A, Oakley R, Simo R, Jeannon JP, Petkar I, Reis Ferreira M, Kong A, Lei M, Guerrero Urbano T. Sambasivan K, et al. Among authors: kong a. Radiother Oncol. 2021 Jul;160:54-60. doi: 10.1016/j.radonc.2021.04.003. Epub 2021 May 3. Radiother Oncol. 2021. PMID: 33845044
Clinical outcomes in relapsed oropharyngeal cancer after definitive (chemo) radiotherapy.
De Felice F, Bird T, Michaelidou A, Jeannon JP, Simo R, Oakley R, Lyons A, Fry A, Cascarini L, Asit A, Thavaraj S, Reis Ferreira M, Petkar I, Kong A, Lei M, Guerrero Urbano T. De Felice F, et al. Among authors: kong a. Oral Dis. 2023 Mar;29(2):595-603. doi: 10.1111/odi.13985. Epub 2021 Aug 27. Oral Dis. 2023. PMID: 34338394
Correlation of the treatment sensitivity of patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO): protocol for a prospective observational study.
Vasiliadou I, Cattaneo C, Chan PYK, Henley-Smith R, Gregson-Williams H, Collins L, Wojewodka G, Guerrero-Urbano T, Jeannon JP, Connor S, Davis J, Pasto A, Mustapha R, Ng T, Kong A. Vasiliadou I, et al. Among authors: kong a. BMJ Open. 2024 Oct 10;14(10):e084176. doi: 10.1136/bmjopen-2024-084176. BMJ Open. 2024. PMID: 39389599 Free PMC article.
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
Vasiliadou I, Grose D, Wilson C, Thapa A, Donnelly O, Lee E, Leslie I, Karim M, Hartley A, Partridge S, Medlow K, De Boisanger J, Metcalf R, Williamson A, Haridass A, Noble D, Mactier K, Walter H, Ma N, De Winton E, Cohen J, Rayner L, Geropantas K, Jankowska P, Mason J, Moleron R, Laws K, Ulahannan D, Nallathambi C, Michaelidou A, Nallamilli S, Raouf S, Palmer K, Bienz M, Karet T, Khalique S, Paterson C, Harrington K, Bhide S, Kong A. Vasiliadou I, et al. Among authors: kong a. Int J Cancer. 2024 Sep 1;155(5):883-893. doi: 10.1002/ijc.34963. Epub 2024 Apr 29. Int J Cancer. 2024. PMID: 38685816
PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer.
Azad A, Arshad M, Generali D, Feldinger K, Gijsen M, Strina C, Cappelletti M, Andreis D, Leek R, Haider S, Kellokumpu-Lehtinen PL, Roxanis I, Harris AL, Shaaban AM, Joensuu H, Kong A. Azad A, et al. Among authors: kong a. Cancer Commun (Lond). 2024 Nov 24. doi: 10.1002/cac2.12632. Online ahead of print. Cancer Commun (Lond). 2024. PMID: 39582148 No abstract available.
Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach.
Galot R, Le Tourneau C, Guigay J, Licitra L, Tinhofer I, Kong A, Caballero C, Fortpied C, Bogaerts J, Govaerts AS, Staelens D, Raveloarivahy T, Rodegher L, Laes JF, Saada-Bouzid E, Machiels JP. Galot R, et al. Among authors: kong a. Ann Oncol. 2018 Dec 1;29(12):2313-2327. doi: 10.1093/annonc/mdy452. Ann Oncol. 2018. PMID: 30307465 Free article. Review.
1,773 results